EDMONTON, Alta.--Bioinformatics software provider BioTools recently announced that it has entered into a strategic partnership with Tokyo-based Sawady Technology to promote, market, and sell BioTools's custom peptide synthesis services to customers in Japan and Asia under a nonexclusive license. The partnership is worth approximately $500,000 in annual peptide synthesis revenues to BioTools, the company stated.